MDMA Teleconference

Teleconference with the FDA concerning MDMA psychotherapy research to treat anxiety, depression and pain in cancer patients, the FDA indicates a willingness to approve a “proof of principle” …

Level of Use of 3,4-methylenedioxymethamphetamine (MDMA)

Investigators: Dafters RI, Duffy F, O’Donnell P, Bouquet C Psychology Department, Glasgow University, Glasgow, Scotland G12 8RT Sponsor(s)/Funding: Self funded Contact: N/A References: Psychopharmacology …

FY 1999 Financial Report

MAPS IRS Form 990 for 1999 in PDF format Fiscal Year June 1, 1998 – May 31, 1999 (FY 98-99) was another year of significant accomplishments. More than twice as much money was devoted to educational …

Follow-up Study of Janiger LSD Research

Investigators: Rick Doblin, Jerry Beck, PhD, Kate Chapman, Maureen Alioto Los Angeles Area, California Contact Sponsor: MAPS The following report constitutes a forty-year+ follow-up interview study of …

MDMA and Memory

Investigators: Karen Bolla, PhD et al. Johns Hopkins University – Baltimore, Maryland Sponsor: NIH Neuropsychological memory testing of MDMA users and controls. Also see Alex Gamma – MDMA and …

MDMA Pharmacokinetics

Investigator: Rudolf Brenneisen, PhD University of Bern, Switzerland Contact: br> Completed and published, just a few subjects. Also see the details and references section.

MDMA Neurotoxicity Study

Investigators: Una McCann, MD, George Ricaurte, MD, PhD Johns Hopkins University – Baltimore, Maryland Sponsor:NIH PET scan study, MDMA Neurotoxicity, MDMA Users vs. Control Group. MAPS Commentary …

Human Psychopharmacology of N,N-dimethyltryptamine

Investigator: Rick Strassman, MD University of New Mexico, USA Contact: Sponsor: NIDA Psychobiological study, finished and published. MAPS Bulletin – Volume 6 Number 1 Autumn 1995 University of New …